Document:

Exhibit 10.8

 

		
        Pankaj Mohan PhD MBA

        Founder & CEO

        7 Clarke Drive, Cranbury

        New Jersey 08512

 

March 27th 2014

 

Ms. Elizabeth Ann Yamashita

 

Dear Ms. Yamashita:

 

The Board of Oncobiologics Inc. is pleased
to extend a full-time employment offer to you. The following are terms and conditions of our offer:

 

Position: “Vice President
– Regulatory and Clinical Affairs”. Please refer to the attached job description that will set expectations of your
employment. You will be reporting to the CEO.

 

Location/Facility: 7 Clarke Drive,
Cranbury, New Jersey, USA 08512

 

Start Date: April 7th
2014

 

Base Pay: $ 8,846 per biweekly pay
period which shall be prorated for part-time engagement. You shall receive the first base pay increase of 2.5% at the receipt of
No Objection Letter for the first biosimilar product Clinical Trial Application. The other base pay increases this year shall be
prorated.

 

Incentive Pay: You will participate
in the success of the company and would be rewarded based on revenue generation (based on EBDITA) and your performance. Your Bonus
Target shall be 50% of your Base Pay in the event that sufficient Revenue is generated to support such a payout as decided by the
Board and that your performance rating is Fully Performing. The Board may make exceptions based on company performance, your performance
and the business environment. The bonus cycle initiates June of each year and bonus shall be prorated within the bonus cycle. The
bonus cycle for this employment shall initiate from the date of employment for proration.

 

Restricted Stock Units: The board
will offer 150,000 Restricted Stock Units (phantom stocks) pursuant to the Company Stock Incentive Plan. The generation of value
from the stock’s will require your expected contribution to the success of the company.

 

In case your job is terminated (voluntarily
or non-voluntarily) prior to liquidation you must return shares back to the company without any payment from the company.

 

Special Off-site Work Provision:
A maximum of 6 weeks of offsite work per employment year shall be permitted subject to prior approval by the CEO.

 

Employee Benefits Program:

		i)	Medical Health Care Plan: Company will offer an medical plan to you;

		ii)	Employee Insurance Plan: Company will offer employee insurance plan.

		iii)	Vacation shall be 3 weeks in an employment year following the company policy.

 

Intellectual Property Protection:
The Company requires you not to disclose any proprietary information from your previous employer/s. The company requires you to
keep confidential

 

T: 609 619
3988   ׀   F: 609 228 4330   ׀   M: 317 514 8886   ׀  
W: www.oncobiologics.com   ׀   E: pankajmohan@oncobiologics.com

United States
Federal Government Supported Biopharmaceutical Company

 

     

     

    

 

		
        Pankaj
Mohan PhD MBA

        Founder & CEO

        7 Clarke Drive, Cranbury

        New Jersey 08512

 

any propriety information that you will
come across in this employment. You will be required to enter into confidentiality agreement with Oncobiologics.

 

Employment At-Will: At all times
during your employment with the Company, you will be an employee at-will. In other words, Oncobiologics Inc. has the right to terminate
your employment with or without cause at any time and you have a right to terminate your employment with Oncobiologics Inc. at
any time.

 

On behalf of the Board, I look forward
to your joining Oncobiologics Inc. and hope that you will find this offer satisfactory in every respect. This offer needs to be
signed by March 31st 2014 and one copy returned to the company.

 

	Sincerely	 
	 	 
	/s/ Pankaj Mohan	 

 

Pankaj Mohan,
Chief Exceutive Officer, Oncobiologics Inc.

		cc:	Members of the Board

 

I accept this offer with the terms and
conditions as outlined in this letter:

 

	/s/ Elizabeth A. Yamashita	 	27 March 2014
	Ms. Elizabeth Ann Yamashita	 	Date

 

T: 609 619
3988   ׀   F: 609 228 4330   ׀   M: 317 514 8886   ׀  
W: www.oncobiologics.com   ׀   E: pankajmohan@oncobiologics.com

United States
Federal Government Supported Biopharmaceutical CompanyExhibit 10.9

 

		
        Pankaj Mohan PhD MBA

        Founder & CEO

        7 Clarke Drive, Cranbury

        New Jersey 08512

 

June 14th 2015

 

Kenneth Bahrt, MD

 

Dear Dr. Bahrt:

 

The Board of Oncobiologics Inc. is pleased
to extend a full-time employment offer to you. The following are terms and conditions of our offer:

 

Position: “Chief Medical Officer”.
Please refer to the attached job description that will set expectations of your employment. You will be reporting to the CEO.

 

Location/Facility: 7 Clarke Drive,
Cranbury, New Jersey, USA 08512

 

Start Date: June 22nd
2015

 

Base Pay: $ 9,616 per biweekly pay
period

 

Incentive Pay: You will participate
in the success of the company and would be rewarded based on revenue generation (based on EBDITA) and your performance. Your Bonus
Target shall be $ 100,000 in a financial year in the event that sufficient Revenue is generated to support such a payout as decided
by the Board and that your performance rating is Fully Performing. The Board may make exceptions based on company performance,
your performance and the business environment. The bonus cycle initiates June of each year and bonus shall be prorated within the
bonus cycle. The bonus cycle for this employment shall initiate from the date of employment for proration.

 

Restricted Stock Units: The board
will offer 100,000 Restricted Stock Units (phantom stocks) or PSUs pursuant to the Company Stock Incentive Plan with a vesting
schedule of 3 and 4 years from the employment start date. The generation of value from the stock’s will require your expected
contribution to the success of the company.

 

In case your job is terminated (voluntarily
or non-voluntarily) prior to liquidation you must return shares back to the company without any payment from the company. In the
event of an Acquisition during your employment at Oncobiologics leading to a sale of the company (liquidation) shall result in
accelerated vesting of your stocks issued by the Company.

 

Employee Benefits Program:

		i)	Medical Health Care Plan: Company will offer an medical plan to you;

		ii)	Employee Insurance Plan: Company will offer employee insurance plan.

		iii)	Vacation shall be 3 weeks in an employment year following the company policy.

 

Intellectual Property Protection:
The Company requires you not to disclose any proprietary information from your previous employer/s. The company requires you to
keep confidential any propriety information that you will come across in this employment. You will be required to enter into confidentiality
agreement with Oncobiologics.

 

T: 609 619
3988   ׀   F: 609 228 4330   ׀   M: 317 514 8886   ׀  
W: www.oncobiologics.com   ׀   E: pankajmohan@oncobiologics.com

United States
Federal Government Supported Biopharmaceutical Company

 

     

     

    

 

		
        Pankaj Mohan PhD MBA

        Founder & CEO

        7 Clarke Drive, Cranbury

        New Jersey 08512

 

Employment At-Will: At all times
during your employment with the Company, you will be an employee at-will. In other words, Oncobiologics Inc. has the right to terminate
your employment with or without cause at any time and you have a right to terminate your employment with Oncobiologics Inc. at
any time.

 

On behalf of the Board, I look forward
to your joining Oncobiologics Inc. and hope that you will find this offer satisfactory in every respect. This offer needs to be
signed by June 19th 2015 and one copy returned to the company.

 

	Sincerely	 
	 	 
	/s/ Pankaj Mohan	 

 

Pankaj Mohan, Chief Executive Officer, Oncobiologics
Inc.

		cc:	Members of the Board

 

I accept this offer with the terms and
conditions as outlined in this letter:

 

	/s/ Kenneth Bahrt	 	06/15/2015
	Kenneth Bahrt, MD	 	Date

 

T: 609 619
3988   ׀   F: 609 228 4330   ׀   M: 317 514 8886   ׀  
W: www.oncobiologics.com   ׀   E: pankajmohan@oncobiologics.com

United States
Federal Government Supported Biopharmaceutical CompanyExhibit 10.10

 

		
        Pankaj Mohan PhD MBA

        Founder & CEO

        7 Clarke Drive, Cranbury

        New Jersey 08512

 

September 12th 2014

 

Oncobiologics – Director Engagement

 

Dear Dr Brady:

 

The Board of Oncobiologics Inc. is pleased
to extend Board of Director engagement to you. This engagement starts from the September 24th 2014. The following represents
our offer to you to join the engagement:

 

Position: “Director –
Oncobiologics Board”.

 

Summary of Role Description: The
Board requests you to help set direction to the Company and enable the Company to reach to the next level of Revenue Generation
and Valuation. The Company expects approximately 10-15 hrs of company related activities per calendar month.

 

This engagement will be indicated in the
company’s website or any other PR media.

 

Location/Facility: At your discretion

 

Total Package:

 

Stock Units

Stocks: The Board will offer to
you 200,000 units of Performance Stock Units (PSUs) per the Company Incentive Plan. Please note that there are no assurances that
it will have any value. The generation of value from the stock’s will require your expected contribution to the success of
the company. The vesting period shall initiate from July 1st 2013 marking your initial engagement as an Advisor Corporate
Strategy. These stock units replace Restricted Stock Units (or RSUs) given to you as an Advisor prior to this engagement.

 

The shares must be returned back
to the company without any payment from the company in the event that the engagement ends (voluntary or involuntary) prior to the
vesting date. Any change to this agreement has to be mutually agreed.

 

Director’s Fee:

The fee will
be $100,000 per fiscal year prorated and paid on a monthly basis.

 

Company’s Benefit: You will
be an independent advisor and not an employee of the Company, and as such will not be provided with employee benefits, such as
but not limited to health insurance.

 

Expenses: The Company will pay at
cost the travel and other expenses incurred by you for company business.

 

Termination: Either party can terminate
this engagement by giving a two weeks’ notice.

 

T: 609 619
3988   ׀   F: 609 228 4330   ׀   M: 317 514 8886   ׀  
W: www.oncobiologics.com   ׀   E: pankajmohan@oncobiologics.com

United States
Federal Government Supported Biopharmaceutical Company

 

     

     

    

 

		
        Pankaj Mohan PhD MBA

        Founder & CEO

        7 Clarke Drive, Cranbury

        New Jersey 08512

 

Confidentiality: You will be requested
to sign a CDA with the company.

 

On behalf of the Board, I look forward
to your joining Oncobiologics Inc. and hope that you will find this offer satisfactory in every respect. This offer needs to be
signed by September 24th 2014 and one copy returned to the company.

 

Sincerely

 

	/s/ Pankaj Mohan	 	9/25/14
	 	 	Date

 

Pankaj Mohan, Chairman and Chief Operating
Officer, Oncobiologics Inc.

		cc:	Members of the Board

 

I accept this offer with the terms and
conditions as outlined in this letter:

 

	/s/ Todd C. Brady	 	9/25/14
	Todd C. Brady, MD PhD	 	Date

 

T: 609 619
3988   ׀   F: 609 228 4330   ׀   M: 317 514 8886   ׀  
W: www.oncobiologics.com   ׀   E: pankajmohan@oncobiologics.com

United States
Federal Government Supported Biopharmaceutical Company

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00253-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00253-of-00352.parquet"}], [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00253-of-00352.parquet"}]]